Vasculitic neuropathy induced by pembrolizumab

Annals of Oncology

Volumn 28, Issue 2, 2017, Pages 433-434

  Aya, F ^a   Ruiz Esquide, V ^a   Viladot, M ^a   Font, C ^a   Prieto Gonzalez S ^a   Prat, A ^a,b   Arance, A ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COBIMETINIB; GLUCOCORTICOID; INFLIXIMAB; IPILIMUMAB; METHYLPREDNISOLONE; PEMBROLIZUMAB; PLACEBO; PREDNISONE; VEMURAFENIB; IMMUNOLOGICAL ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; CANCER STAGING; CASE REPORT; COLITIS; CONVALESCENCE; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; HUMAN; LETTER; LIVER METASTASIS; MELANOMA; MIDDLE AGED; MUSCLE BIOPSY; NERVE BIOPSY; NERVE CONDUCTION; PARESTHESIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN METASTASIS; SMALL VESSEL VASCULITIS; TREATMENT OUTCOME; CHEMICALLY INDUCED; LIVER TUMOR; PATHOLOGY; SECONDARY; VASCULITIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; FEMALE; HUMANS; LIVER NEOPLASMS; MELANOMA; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; VASCULITIS;

EID: 85019547045     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw613     Document Type: Letter

References (4)

1. Deeks ED. Pembrolizumab: A review in advanced melanoma. Drugs 2016; 76: 375-386.
2. Weber JS, Yang JC, Atkins MB, Disis ML. Toxicities of immunotherapy for the practitioner. J Clin Oncol 2015; 33: 2092-2099.
3. de Maleissye MF, Nicolas G, Saiag P. Pembrolizumab-induced demyelinating polyradiculoneuropathy. N Engl J Med 2016; 375: 296-297.
4. Aya F, Gaba L, Victoria I et al. Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis. ESMO Open 2015; 1.